1. Home
  2. APGE vs NTB Comparison

APGE vs NTB Comparison

Compare APGE & NTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APGE
  • NTB
  • Stock Information
  • Founded
  • APGE 2022
  • NTB 1858
  • Country
  • APGE United States
  • NTB Bermuda
  • Employees
  • APGE N/A
  • NTB N/A
  • Industry
  • APGE Biotechnology: Biological Products (No Diagnostic Substances)
  • NTB Commercial Banks
  • Sector
  • APGE Health Care
  • NTB Finance
  • Exchange
  • APGE Nasdaq
  • NTB Nasdaq
  • Market Cap
  • APGE 2.0B
  • NTB 1.9B
  • IPO Year
  • APGE 2023
  • NTB 2016
  • Fundamental
  • Price
  • APGE $37.87
  • NTB $44.64
  • Analyst Decision
  • APGE Strong Buy
  • NTB Buy
  • Analyst Count
  • APGE 5
  • NTB 3
  • Target Price
  • APGE $95.40
  • NTB $51.33
  • AVG Volume (30 Days)
  • APGE 431.7K
  • NTB 192.4K
  • Earning Date
  • APGE 08-11-2025
  • NTB 10-21-2025
  • Dividend Yield
  • APGE N/A
  • NTB 4.42%
  • EPS Growth
  • APGE N/A
  • NTB 14.60
  • EPS
  • APGE N/A
  • NTB 4.96
  • Revenue
  • APGE N/A
  • NTB $588,897,000.00
  • Revenue This Year
  • APGE N/A
  • NTB $3.31
  • Revenue Next Year
  • APGE N/A
  • NTB N/A
  • P/E Ratio
  • APGE N/A
  • NTB $9.12
  • Revenue Growth
  • APGE N/A
  • NTB 2.95
  • 52 Week Low
  • APGE $26.20
  • NTB $34.77
  • 52 Week High
  • APGE $63.50
  • NTB $46.89
  • Technical
  • Relative Strength Index (RSI)
  • APGE 51.33
  • NTB 48.13
  • Support Level
  • APGE $35.68
  • NTB $42.98
  • Resistance Level
  • APGE $38.75
  • NTB $45.83
  • Average True Range (ATR)
  • APGE 1.59
  • NTB 0.85
  • MACD
  • APGE 0.19
  • NTB -0.01
  • Stochastic Oscillator
  • APGE 69.51
  • NTB 56.08

About APGE Apogee Therapeutics Inc.

Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.

About NTB Bank of N.T. Butterfield & Son Limited (The) Voting

Bank of N.T Butterfield & Son Ltd is a full-service bank and wealth manager. It operates the business through three geographic segments, Bermuda, Cayman Islands, the Channel Islands and the UK. The company offers banking services, comprised of retail and corporate banking, and wealth management, which consists of trust, private banking, and asset management. The company generates a majority of its revenue from Bermuda, and the Cayman Islands segments.

Share on Social Networks: